Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisition - Endpoints News
Business
Bris?tol My?ers Squibb is delv?ing fur?ther in?to cell ther?a?pies with the $1.5 bil?lion cash pur?chase of Or?bital Ther?a?peu?tics, the New Jer?sey phar?ma

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Popular Categories

Stay Connected

Loading...